<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">HPR</journal-id><journal-title-group><journal-title>Health Psychology Research</journal-title></journal-title-group><issn>TBA</issn><eissn>2420-8124</eissn><publisher><publisher-name>Health Psychology Research</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52965/001c.129550</article-id><article-categories><subj-group subj-group-type="heading"><subject>General</subject></subj-group></article-categories><title>Treatment of cognitive deficits in schizophrenia using a new technique of Cognitive Training in Virtual Reality: a pilot study</title><url>https://healthpr.org/journal/HPR/13/1/10.52965/001c.129550</url><author>BissoEmanuele,CaponnettoPasquale,AuditoreRoberta,PulvirentiAlfredo,AgugliaEugenio,AvincolaGabriele,FakhrouAbdulnaser,Salvina SignorelliMaria</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>13</volume><issue>1</issue><history><date date-type="pub"><published-time>2025-03-23</published-time></date></history><abstract>Background
Cognitive impairments, prevalent in 75-80% of schizophrenia patients, severely impact rehabilitation and quality of life. Current therapies, including antipsychotics, have limited success in addressing these deficits. Virtual reality (VR) offers a promising avenue for cognitive training by providing realistic, interactive scenarios for skill application.
&amp;nbsp;
Objective
This study evaluates the efficacy of a novel VR-based cognitive training intervention in improving cognitive deficits in schizophrenia compared to standard treatment as usual (TAU).
&amp;nbsp;
Methods
A randomized clinical trial was conducted with 16 inpatients diagnosed with schizophrenia. Participants were allocated to either a VR intervention group, receiving six weekly sessions of VR cognitive training, or a control group undergoing TAU. Pre- and post-intervention assessments included the Trail Making Test, Positive and Negative Syndrome Scale, Frontal Assessment Battery, and Tower of London test. Two VR scenarios, &amp;ldquo;Supermarket&amp;rdquo; and &amp;ldquo;Beach,&amp;rdquo; were developed to target working memory, attention, and executive functioning. Data were analyzed using t-tests and linear mixed-effects models.
&amp;nbsp;
Results
The VR intervention group showed significant improvements in frontal lobe functioning as measured by the Frontal Assessment Battery (FAB) and trends toward better executive function and attention. Scenario-specific analyses revealed reduced errors, omissions, and execution times across sessions. However, broader cognitive and psychiatric symptom improvements were limited and did not persist after multiple-comparison corrections.
&amp;nbsp;
Conclusion
VR cognitive training shows potential as an innovative tool for enhancing executive functioning in schizophrenia patients. While immediate task performance improved, broader cognitive impacts and psychiatric symptom reductions were minimal. Future research should focus on long-term efficacy, functional outcomes, and scalability of VR interventions.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>


1.Reichenberg A. The assessment of neuropsychological functioning in schizophrenia.&amp;nbsp;Dialogues in clinical neuroscience. 2022;12(3):383-392. doi:10.31887/​DCNS.2010.12.3/​areichenberg


Google Scholar



2.Davidson M, Galderisi S, Weiser M, et al. Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST).&amp;nbsp;American journal of psychiatry. 2009;166(6):675-682. doi:10.1176/​appi.ajp.2008.08060806


Google Scholar



3.Mortimer AM, Joyce E, Balasubramaniam K, Choudhary PC, Saleem PT. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.&amp;nbsp;Human Psychopharmacology: Clinical and Experimental. 2007;22(7):445-454. doi:10.1002/​hup.865


Google Scholar



4.Woodward ND, Purdon SE, Meltzer HY, Zald DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.&amp;nbsp;The International Journal of Neuropsychopharmacology. 2005;8(3):457-472. doi:10.1017/​s146114570500516x


Google Scholar



5.Bisso E, Signorelli MS, Milazzo M, et al. Immersive Virtual Reality Applications in Schizophrenia Spectrum Therapy: A Systematic Review.&amp;nbsp;International Journal of Environmental Research and Public Health. 2020;17(17). doi:10.3390/​ijerph17176111


Google Scholar



6.Schroeder AH, Bogie BJM, Rahman TT, Th&amp;eacute;rond A, Matheson H, Guimond S. Feasibility and Efficacy of Virtual Reality Interventions to Improve Psychosocial Functioning in Psychosis: Systematic Review.&amp;nbsp;JMIR Mental Health. 2022;9(2). doi:10.2196/​28502


Google Scholar



7.Barlati S, Nibbio G, Vita A. Evidence-based psychosocial interventions in schizophrenia: a critical review.&amp;nbsp;Current Opinion in Psychiatry. 2024;37(3):131-139. doi:10.1097/​yco.0000000000000925


Google Scholar



8.Reitan RM. Validity of the Trail Making Test as an Indicator of Organic Brain Damage.&amp;nbsp;Perceptual and Motor Skills. 2016;8(3):271-276. doi:10.2466/​pms.1958.8.3.271


Google Scholar



9.Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia.&amp;nbsp;Schizophrenia Bulletin. 1987;13(2):261-276. doi:10.1093/​schbul/​13.2.261


Google Scholar



10.Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB.&amp;nbsp;Neurology. 2000;55(11):1621-1626. doi:10.1212/​wnl.55.11.1621


Google Scholar



11.Shallice T. Specific impairments of planning.&amp;nbsp;Philosophical Transactions of the Royal Society of London B, Biological Sciences. 1997;298(1089):199-209. doi:10.1098/​rstb.1982.0082


Google Scholar



12.Freeman D, Yu LM, Kabir T, et al. Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange).&amp;nbsp;BMJ Open. 2019;9(8). doi:10.1136/​bmjopen-2019-031606


Google Scholar



13.Schlosser DA, Fisher M, Gard D, Fulford D, Loewy RL, Vinogradov S. Motivational deficits in individuals at-risk for psychosis and across the course of schizophrenia.&amp;nbsp;Schizophrenia Research. 2014;158(1-3):52-57. doi:10.1016/​j.schres.2014.06.024


Google Scholar



14.Keefe RSE, Davis VG, Atkins AS, et al. Validation of a Computerized test of Functional Capacity.&amp;nbsp;Schizophrenia Research. 2016;175(1-3):90-96. doi:10.1016/​j.schres.2016.03.038


Google Scholar



15.Badcock JC, Dragovic M, Dawson L, Jones R. Normative Data for Rey&amp;rsquo;s Auditory Verbal Learning Test in Individuals with Schizophrenia.&amp;nbsp;Archives of Clinical Neuropsychology. 2011;26(3):205-213. doi:10.1093/​arclin/​acr005


Google Scholar



16.Miranda B, Rego PA, Romero L, Moreira PM. Application of Immersive VR Serious Games in the Treatment of Schizophrenia Negative Symptoms.&amp;nbsp;Computers. 2024;13(2). doi:10.3390/​computers13020042


Google Scholar



17.Shen ZH, Liu MH, Wu Y, Lin QQ, Wang YG. Virtual-reality-based social cognition and interaction training for patients with schizophrenia: A preliminary efficacy study.&amp;nbsp;Frontiers in Psychiatry. 2022;13. doi:10.3389/​fpsyt.2022.1022278


Google Scholar</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
